DFFN insider filings

Diffusion Pharmaceuticals Inc. — 40 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-07-05. Screen DFFN transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for DFFN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Diffusion Pharmaceuticals Inc.

FiledFormInsiderReported transactionsSource
2023-07-054LANCHONEY DIANA M — DirectorOption exercise (M): 232 · Disposition to issuer (D): 85 · Option exercise (M): 232 (derivative) @ $0EDGAR
2023-06-024Hollingsworth Jane H — DirectorOption exercise (M): 183 · Disposition to issuer (D): 68 · Option exercise (M): 183 (derivative) @ $0EDGAR
2023-04-034LANCHONEY DIANA M — DirectorOption exercise (M): 232 · Disposition to issuer (D): 85 · Option exercise (M): 232 (derivative) @ $0EDGAR
2023-03-034Hollingsworth Jane H — DirectorOption exercise (M): 183 · Disposition to issuer (D): 68 · Option exercise (M): 183 (derivative) @ $0EDGAR
2023-02-034Cobuzzi Robert Joseph Jr. — President & CEO, DirectorOption exercise (M): 327 · Disposition to issuer (D): 121 · Option exercise (M): 327 (derivative) @ $0EDGAR
2022-12-024Hollingsworth Jane H — DirectorOption exercise (M): 183 · Disposition to issuer (D): 68 · Option exercise (M): 183 (derivative) @ $0EDGAR
2022-11-024Cobuzzi Robert Joseph Jr. — President & CEO, DirectorOption exercise (M): 327 · Disposition to issuer (D): 121 · Option exercise (M): 327 (derivative) @ $0EDGAR
2022-09-024Hollingsworth Jane H — DirectorOption exercise (M): 183 · Disposition to issuer (D): 67 · Option exercise (M): 183 (derivative) @ $0EDGAR
2022-08-264JAEGER RAVEN — Chief Regulatory OfficerGrant/award (A): 8,000 (derivative) @ $0EDGAR
2022-08-034Cobuzzi Robert Joseph Jr. — President & CEO, DirectorOption exercise (M): 327 · Disposition to issuer (D): 121 · Option exercise (M): 327 (derivative) @ $0EDGAR
2022-06-024Hollingsworth Jane H — DirectorOption exercise (M): 183 · Disposition to issuer (D): 67 · Option exercise (M): 183 (derivative) @ $0EDGAR
2022-05-034Cobuzzi Robert Joseph Jr. — President & CEO, DirectorOption exercise (M): 327 · Disposition to issuer (D): 121 · Option exercise (M): 327 (derivative) @ $0EDGAR
2022-04-194Cobuzzi Robert Joseph Jr. — President & CEO, DirectorConversion (C): 100 @ $25 · Conversion (C): 100 (derivative) @ $25EDGAR
2022-04-194ELDER WILLIAM ROBERT — GC & SecretaryConversion (C): 100 @ $25 · Conversion (C): 100 (derivative) @ $25EDGAR
2022-03-224ELDER WILLIAM ROBERT — GC & SecretaryPurchase (P): 5,000 (derivative) @ $0.50EDGAR
2022-03-224Cobuzzi Robert Joseph Jr. — President & CEO, DirectorPurchase (P): 5,000 (derivative) @ $0.50EDGAR
2022-02-024Cobuzzi Robert Joseph Jr. — President & CEO, DirectorOption exercise (M): 16,350 · Disposition to issuer (D): 6,049 · Option exercise (M): 16,350 (derivative) @ $0EDGAR
2022-02-024/ACobuzzi Robert Joseph Jr. — President & CEO, DirectorOption exercise (M): 16,350 · Disposition to issuer (D): 6,049 · Option exercise (M): 16,350 (derivative) @ $0EDGAR
2022-01-314Hornung William Karl — Chief Financial OfficerGrant/award (A): 305,743 (derivative) @ $0EDGAR
2022-01-314GALLOWAY CHRISTOPHER D — Chief Medical OfficerGrant/award (A): 305,743 (derivative) @ $0EDGAR
2022-01-314ELDER WILLIAM ROBERT — GC & SecretaryGrant/award (A): 305,743 (derivative) @ $0EDGAR
2022-01-314Cobuzzi Robert Joseph Jr. — President & CEO, DirectorGrant/award (A): 764,357 (derivative) @ $0EDGAR
2021-11-034Cobuzzi Robert Joseph Jr. — President & CEO, DirectorOption exercise (M): 16,350 · Option exercise (M): 16,350 (derivative) @ $0EDGAR
2021-10-154LANCHONEY DIANA M — DirectorGrant/award (A): 83,300 (derivative) @ $0 · Grant/award (A): 83,300 (derivative) @ $0 · Grant/award (A): 69,400 (derivative) @ $0EDGAR
2021-07-064Hollingsworth Jane H — DirectorGrant/award (A): 83,300 (derivative) @ $0EDGAR
2021-07-064LEVIN ALAN G — DirectorGrant/award (A): 83,300 (derivative) @ $0EDGAR
2021-07-064Adams Robert W — DirectorGrant/award (A): 83,300 (derivative) @ $0EDGAR
2021-07-064Francois Eric — DirectorGrant/award (A): 83,300 (derivative) @ $0 · Grant/award (A): 83,300 (derivative) @ $0 · Grant/award (A): 69,400 (derivative) @ $0EDGAR
2021-07-064Giles Mark T — DirectorGrant/award (A): 83,300 (derivative) @ $0EDGAR
2021-05-174Hollingsworth Jane H — DirectorPurchase (P): 32,786 @ $0.61EDGAR
2021-03-044Cobuzzi Robert Joseph Jr. — President & CEO, DirectorGrant/award (A): 53,713 (derivative) @ $0 · Grant/award (A): 161,139 (derivative) @ $0EDGAR
2021-03-044ELDER WILLIAM ROBERT — GC & SecretaryGrant/award (A): 87,684 (derivative) @ $0 · Grant/award (A): 62,522 (derivative) @ $0EDGAR
2021-03-044GALLOWAY CHRISTOPHER D — Chief Medical OfficerGrant/award (A): 27,180 (derivative) @ $0 · Grant/award (A): 81,537 (derivative) @ $0EDGAR
2021-03-044Hornung William Karl — Chief Financial OfficerGrant/award (A): 122,771 (derivative) @ $0 · Grant/award (A): 80,069 (derivative) @ $0EDGAR
2020-11-184Cobuzzi Robert Joseph Jr. — President & CEO, DirectorPurchase (P): 14,000 @ $0.66EDGAR
2020-11-184ELDER WILLIAM ROBERT — GC & SecretaryPurchase (P): 10,000 @ $0.67 · Purchase (P): 5,000 @ $0.63EDGAR
2020-10-214GALLOWAY CHRISTOPHER D — Chief Medical OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2020-10-144ELDER WILLIAM ROBERT — GC & SecretaryGrant/award (A): 70,000 (derivative) @ $0EDGAR
2020-10-014Hollingsworth Jane H — DirectorGrant/award (A): 67,400 (derivative) @ $0 · Grant/award (A): 54,900 (derivative) @ $0EDGAR
2020-09-114Cobuzzi Robert Joseph Jr. — President & CEO, DirectorGrant/award (A): 475,000 (derivative) @ $0EDGAR

Recent 8-K events — Diffusion Pharmaceuticals Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-298-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-148-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-138-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-288-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-108-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DFFN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs